
Venture capital
Samsara BioCapital
Samsara BioCapital is a Palo Alto-based venture investor focused on biotechnology and therapeutics. It is run by scientists, physicians and drug developers and holds a large portfolio of private and public biotech companies.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Samsara BioCapital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Samsara BioCapital joined, from press and the firm’s own posts.
Every round Samsara BioCapital joined
Round sizes, Samsara BioCapital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Samsara BioCapital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Samsara BioCapital
Events where Samsara BioCapital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Samsara BioCapital is based in Ireland. It also has an office in Palo Alto.
3 fund vehicles are on public registers (SEC adviser filings), including SAMSARA BIOCAPITAL, L.P., SAMSARA OPPORTUNITY FUND, L.P. and SMSR B1, L.P.
Samsara BioCapital lists 75 portfolio companies on its website, including A2 Biotherapeutics, Inc., Abcuro, Inc., Abivax SA, Acelyrin, Inc and Alamar Biosciences, Inc..
Firms whose websites list some of the same companies include Foresite Capital, THIRD ROCK VENTURES, LLC. and Advent Life Sciences.
Know before Samsara BioCapital’s next round is announced.
PRO tracks Samsara BioCapital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.